ABSTRACT: Experiments were conducted in sheep to determine excretory characteristics of sodium chlorate after a single oral dose. In Exp. 1, lambs ( n = 16; age = 8.1 ± 1.7 d; BW = 8.2 ± 1.1 kg; mean ± SD) were dosed orally with 0, 30, 60, or 90 mg/kg BW of sodium chlorate. Twenty-four hours after exposure chlorate residues were dose dependent (P < 0.05) in small intestinal contents, serum, and urine, but chlorate residues were not consistently detected in cecal or colonic contents. In Exp. 2, non-pregnant yearling ewes (BW = 74.8 ± 5.6 kg; mean ± SD) were orally dosed with 0, 150, 300, or 450 mg/kg BW of sodium chlorate. Across dose, chlorate residues averaged from 47 to 114, 0.6 to 4.5, and were not detectable to 0.2 μg/mL at 24, 48, and 72 h, respectively, in serum of treated animals; in feces, residues averaged 29 to 82, 0.8 to 14, and were not detectable to 1.2 μg/mL at the same respective time periods. In Exp. 3, six lactating ewes (BW = 76.3 ± 8.0 kg) were dosed orally with 450 mg/kg BW of sodium chlorate; residues were measured in serum, milk, urine and feces in periods encompassing 0 to 8, 8 to 16, 16 to 24, 24 to 32, 32 to 40, and 40 to 48 h. Chlorate residues in milk were detectable at all time periods with concentrations averaging from 287 ± 67 to 26 ± 13 μg/ mL during the fi rst and last collection periods, respectively. Urine contained the greatest concentration of chlorate at each time point and averaged 480 ± 268 μg/ mL at 40 to 48 h. Depletion half-lives in serum, milk, urine, and feces were estimated to be 6.2, 27, 19, and 10 h, respectively; milk, urinary and fecal half-lives are likely overestimated due to the fact that 8-h sample pools were used in half-life estimations. In Exp. 4, three wethers (BW = 87.1 ± 5.3 kg) each were orally dosed with 14 or 42 mg/kg BW of sodium chlorate; blood samples were serially collected for 48 h, and urine samples were collected at 0 to 8, 8 to 16, 16 to 24, 24 to 36, and 36 to 48 h. Estimates of absorption and elimination half-lives based on serum chlorate concentrations were about 0.4 and 2.5 h, respectively. Urine collected during the 6 h immediately following dosing contained the greatest concentrations of chlorate residues relative to subsequent collection periods. Rapid removal of chlorate from the gastrointestinal lumen suggests that effects of chlorate on colonic and fecal gastrointestinal bacteria may occur through mechanisms other than direct luminal contact between microbe and chlorate salts.
INTRODUCTION

Gastrointestinal (GI) reservoirs of pathogenic
Escherichia coli in maternal ewes may serve as causative agents of neonatal dysentery (Merck, 2005) , a disease which causes signifi cant lamb mortality and economic losses for producers (Dohoo et al., 1985; Doré et al., 1987; SID, 2002) . For sheep fl ocks managed in confi ned, high-density lambing systems (e.g., shed-lambing) Taylor et al. (2011) have hypothesized that chlorate salts could be administered to ewes just before parturition to reduce enteropathogen shedding and subsequent infection of lambs.
Numerous trials in hogs (Anderson et al., 2001a,b) , cattle (Anderson et al., 2005) , broilers , laying hens and turkeys (Moore et al., 2006) have demonstrated that oral sodium chlorate consistently reduces numbers of GI or fecal E. coli O157:H7 or Salmonella Typhimurium cfu or both by 2 to 3 log units. Callaway et al. (2003) and Edrington et al. (2003) established that chlorate salts are effective at reducing concentrations of gram-negative pathogens in sheep.
The rate(s) at which chlorate is eliminated from the GI tract either through absorption, microbial reduction to chloride or elimination through defecation, or all 3, could have major effects on the chlorate doses that must be delivered for optimal effi cacy. Therefore, the objectives of this experiment were to 1) describe the serum pharmacokinetics of chlorate in sheep after oral dosing; 2) determine the elimination patterns of parent chlorate in sheep; and 3) determine the extent of methemoglobin formation, a marker of chlorate toxicity, in blood of sheep provided low oral doses of sodium chlorate.
MATERIALS AND METHODS
Studies were conducted at the USDA Biosciences Laboratory in Fargo, ND and at the U.S. Sheep Experiment Station near Dubois, ID. Animal experiments were approved by the respective Institutional Animal Care and Use Committees before initiation of study protocols.
Sodium chlorate is a salt, and in aqueous matrices it is dissociated into its component anion (ClO 3 -) and cation (Na + ). The analytical methods employed in this manuscript measured chlorate as the anion, but data are expressed on a sodium chlorate equivalent basis because all standard curves were prepared from sodium chlorate standards. Thus, chlorate and sodium chlorate are used interchangeably in this treatise.
Experiments
Exp. 1, GI Fate of Chlorate in Neonatal Lambs.
Details of the experimental design, animal care and nutrition, and sample collection were described by Taylor et al. (2011) . Briefl y, crossbred (50% Suffolk, 25% Polypay, and 25% Columbia) lambs (n = 16; age = 8.1 ± 1.7 d; BW = 8.2 ± 1.1 kg; mean ± SD) were randomly and equally assigned to 4 groups, and groups were randomly assigned to 4 treatments. Treatments were single oral doses of saline (control; NaCl, 30 mg/kg BW) or 30, 60, or 90 mg/kg BW of sodium chlorate. Stock solutions of NaClO 3 (CAS: 7775-09-9; >99% purity; Acros Organics, NJ) and NaCl were prepared in double-distilled H 2 O at a fi nal concentration of 200 mg/mL. Treatment doses were adjusted according to BW, lambs were provided their respective dose treatments in 10 mL of water via a stomach tube and tubes were fl ushed with 10 mL of water before removal. Twenty-four h later, blood samples were collected (Corvac Serum Separation Tube with clot activator and polymer gel, 16×100 mm; Sherwood-Davis and Geck, St. Louis, MO), serum was separated following centrifugation (15 min at 1,500 × g) and stored (< −20 °C), and lambs were subsequently euthanized by intravenous injection of sodium pentobarbital (90 mg/kg BW; Beuthanasia-D Special; ScheringPlough Animal Health Corp., Union, NJ). Urine, small intestine, cecum, and colon contents were immediately collected and frozen (< −20°C) for chlorate analyses.
Exp. 2: Fecal Excretion of Chlorate from Yearling Ewes. Details of the experimental design, animal care and nutrition, and sample collection were described by Taylor et al. (2011) . Briefl y, Rambouillet, nonpregnant, yearling ewes (n = 44; 74.8 ± 5.6 kg) were randomly and equally allocated to 4 groups, and groups were randomly assigned to 4 treatments. Treatments were single, oral doses of saline (control, NaCl; 150 mg/kg BW) or 150, 300 or 450 mg/kg of NaClO 3 /kg of BW. According to treatment and ewe BW, corresponding weights of NaClO 3 (Arcos Organics) or NaCl were dissolved into 150 mL of doubledistilled H 2 O, ewes were provided the respective dose treatments via a stomach tube, and tubes were fl ushed with 30 mL of water before removal. Fecal grab samples were collected before dosing (0 h) and at 24, 48 and 72 h after dosing and frozen at −20 °C until chlorate analysis.
Exp. 3: Elimination of Chlorate from Lactating Ewes. Lactating Polypay ewes (n = 6; 76.3 ± 8.0 kg; mean ± SD) were placed in metabolism crates (0.5×1 m) and were orally dosed with 450 mg of NaClO 3 /kg of BW. Ewes were 44.4 ± 9.1 d (mean ± SD) postpartum at dosing. Before dosing, ewes were individually housed in indoor pens (2.4×2.4 m) with their lambs. Ewes had ad libitum access to water and were fed 3 times daily a diet that was formulated to meet the daily nutrient needs (NRC, 2007) of mature ewes nursing single lambs. Over a 28-d period, ewes were trained to be milked with a milking machine (Hamby Dairy Supply, Maysville, MO), within a metabolism crate (0.5×1 m). For the fi rst 14 d of training, ewes were separated daily from lambs for 3 h and then milked at 0600. For the next 7 d, ewes were trained to be milked twice daily (0600 and 1400 h) with 0-and 6-h separation periods from lambs before milking, respectively. During the 14 to 21 d training period, oxytocin (1.5 mL intramuscularly; 20 USP units/mL; Bimeda-MTC Animal Health, Inc., Cambridge, Ontario, Canada) was given at the 1400-h milking to facilitate milk ejection. For the fi nal 7 d of training, ewes were milked 3 times daily at 0600, 1400, and 2000 h with 0-, 6-and 6-h separation peri-ods from the lambs before milking, respectively. During the fi nal training period, milk output was measured at the 1400 h milking 4 d (without oxytocin injection) and 2 d (with oxytocin injection) before dosing ewes with NaClO 3 ; BW were measured 3 d before dosing. Ewes were ranked by milk production, and pairs of ewes, beginning with ewes with the greatest milk production, were assigned to 1 of 3 consecutive, 48-h experimental periods.
For each experimental period, indwelling catheters were inserted into a jugular vein of ewes 8 h before treatment doses were given. Lambs were weaned from ewes and ewes were placed in metabolism crates; water and feed were offered as described above. According to ewe BW, corresponding weights of NaClO 3 (Acros Organics) were dissolved into 200 mL of double-distilled H 2 O, ewes were provided their respective dose treatment via a stomach tube (time = h 0), and tubes were fl ushed with 30 mL double-distilled H 2 O before removal. Beginning at h 0, cumulative feces and urine were collected in 8-h periods (h 0600 to 1359, 1400 to 2159 and 2200 to 0559); collection containers were maintained on ice during collection. Ewes were milked immediately before the dose treatment and at the end of each collection period. All samples were weighed, mixed and subsampled, and subsamples were stored (< −20 °C) until analyses. Whole blood samples were collected with a syringe and transferred into serum separator tubes (Corvac Serum Separation Tube) at 0, 0.25, 0.5, 1, 2, 3, 4, 6, 8, 16, 24, 32, 40 and 48 h respective to dose treatment. Serum was separated following centrifugation (15 min at 1,500 × g) and stored (< −20 °C) until analyses.
Exp. 4: Kinetics and Fate of Low-Dose Sodium Chlorate and Methemoglobin Formation in Wethers.
Polypay wethers (n = 6; 87.1 ± 5.3 kg; mean ± SD) were housed in pairs on concrete-fl oored pens (3.2 m 2 ) covered with wood shavings which were replaced on a daily basis. Wethers were provided 0.22 kg of cracked corn per day and ad libitum access to an alfalfa-hay grass hay mix and water during facility adaptation (at least 3 d), metabolism-crate training and experimental periods.
Sheep were randomly allocated to 2 treatments consisting of 14 or 42 mg/kg BW of oral sodium chlorate. Treatment doses were selected to mimic the daily allotment (42 mg/kg BW) or one-third the daily allotment (14 mg/kg BW) of sodium chlorate that were previously provided to cattle (Smith et al., 2005a) . Wethers were provided their respective chlorate (sodium salt, 99.9% purity; EKA Chemical Co, Marietta, GA) treatments as a single bolus (contained within a gelatin capsule) via a balling gun (Time 0). Blood samples (4-mL, BD sodium heparin and 10 mL, BD-SST clot activator tubes; Becton-Dickinson and Co., NJ) were collected at 0.25, 0.5, 1, 2, 3, 4, 6, 8, 12, 18, 24, 30, 36, and 48 h postdosing. Heparinized whole blood was used immediately for the determination of methemoglobin as described below; serum (30 min clotting time) was separated and collected following centrifugation (1200 x g for 10 min). Urine and feces were collected into containers maintained on ice into periods covering 0 to 6, 6 to 12, 12 to 24, 24 to 36 and 36 to 48 h after dosing. Samples were frozen and stored at −20 °C until analysis.
Analyses
Chlorate Analyses. Blood serum, urine, milk, GI content and fecal chlorate were analyzed using the colorimetric, ion-chromatographic or liquid chromatographic mass spectrometric (LCMS) methods described by Smith and Taylor (2011) . A colorimetric method was used for blood serum and milk samples containing concentrated levels of chlorate; the ion chromatographic method was used for urine and fecal samples containing concentrated levels of chlorate; and the LCMS method was used for all matrices (except milk) which contained concentrations of chlorate less than 5 μg/mL. Limits of quantitation for individual analyses were dependent upon matrix, sample sizes, and with ion chromatography, injection volume. Therefore, limits of quantitation for individual analyses are presented with the results.
Methemoglobin Analysis. Methemoglobin was measured using the method of Evelyn and Malloy (1938) as modifi ed by Hegesh et al. (1970) . Briefl y, duplicate aliquots (200 μL) of whole blood were hemolyzed with 550 μL of ice-cold purifi ed water. Hemolyzed samples were immediately vortex mixed and allowed to sit on ice for 3 min; 250 μL of ice-cold 0.5 M phosphate buffer (pH 7.2) were then added and vortex mixed. Samples were centrifuged at 15,000 x g for 15 min at 5 °C. Hemosylate aliquots were placed in paired microcuvettes labeled A1 (600 μL) and A2 (50 μL); 550 μL of 1% potassium ferricyanide in phosphate buffer were immediately added to microcuvette A2 and absorbencies (632 nm) of A1 and A2 were recorded. Neutral sodium cyanide (20 μL) was added to each microcuvette; the contents gently vortexed, allowed to sit for 1 min, and absorbencies (632 nm) were measured again (A3 and A4, respectively). The percentage met hemoglobin in each sample was calculated by:
The assay was validated by preparing blood containing 0, 2.5, 5, 7.5, and 10% methemoglobin and subsequently measuring the percentage methemoglobin. Fresh sheep blood (4 mL) was treated with 10 mg of sodium nitrite for a 5 min period prior to rinsing with 0.9% saline and hemolyzing with ice-cold water. The methemoglobin was mixed with freshly prepared blood hemosylate to the proper ratios and the methemoglobin assay was conducted.
Calculations and Statistics
Kinetic Parameter Estimates. Kinetic parameters (A, D, α, and β) were estimated on a per animal basis from blood serum time course data with non-compartmental methods (Gabrielsson and Weiner, 1997) using PKSolutions software (Summit Research Services; Montrose, CO). Parameter estimates gained from the curve-stripping technique were plotted using the following model:
where C is the serum concentration of sodium chlorate at time, t; A and D are Y intercepts of lines having slopes of α and β, respectfully. Lines predicted by Ae -αt and De -βt characterize, in practice, the absorption and elimination phases of sodium chlorate. Addition of a third exponential term decreased the overall fi t of the data. Reported values are means and standard deviations of parameter estimates from 6 animals.
Data Analyses. The effect of dose on residue concentrations in GI contents or excreta were determined by linear regression with 0 doses (controls) omitted from the regression analyses (GraphPad Prism 5.0; GraphPad Software, San Diego, CA) so the effect of the 0 dose would not bias the determination of whether the dependent variable was related to chlorate dose.
RESULTS AND DISCUSSION
Exp. 1: GI Fate of Chlorate in Neonatal Lambs
Concentrations of sodium chlorate in GI contents, serum and urine collected 24 h after dosing of lambs are shown in Table 1 . At 24 h, sodium chlorate was present in the small intestines of all lambs, and small intestinal chlorate concentration was linear with respect to dose (P < 0.02; r 2 = 0.44). In co ntrast, cecal sodium chlorate was detectable only in 1 of 4 lambs at the 30 and 60 mg/ kg doses and in 2 of 4 animals at the 90 mg/kg dose. Similarly, colon concentrations of chlorate were detectable in 2 of 4 lambs at the 30 mg/kg dose and in 1 of 4 lambs at the 60 and 90 mg/kg doses. With the exception of 1 lamb at the 90 mg/kg BW dose, concentrations of chlorate in the cecum and colon were always less than 1 μg/g. Because of the low to absent residues of sodium chlorate present in cecum and colon contents, no relationship with dose and chlorate concentration could be established. In serum, chlorate concentration was linear with respect to dose (P < 0.0003; r 2 = 0.76). Within dose, average urinary chlorate concentrations were 10-fold or greater than in the small intestine at 24 h. Like small intestinal and serum chlorate, urinary chlorate concentrations increased (P < 0.02; r 2 = 0.53) with dose.
Collectively, these results suggest that neonatal lambs have a great capacity for chlorate absorption and excretion. Based on the paucity of chlorate remaining in cecal and colon contents, one might predict that chlorate would have no effect on microbes in the lower gut of lambs. Such was not the case, however. Taylor et al. (2011) reported that for these lambs, colonic, but not ce- Table 1 . Concentrations (mean ± SD) of sodium chlorate in digesta removed from segments of gastrointestinal tracts and in serum and urine of neonatal lambs 24 h after oral dosing with 0, 30, 60 or 90 mg/kg BW of sodium chlorate (Exp. 1). The limit of quantitation (LOQ) of the most sensitive assay (LCMS) was 0.10 μg/g for a 1-g intestinal contents sample, and 0.50 μg/mL for a 25-μL serum sample; urine samples were assayed by ion chromatography with conductivity detection (LOQ of 100 μg/mL; 0.25 mL urine sample) cal, E. coli concentrations were reduced (P < 0.05) 24 h after sodium chlorate was orally dosed.
Exp. 2: Fecal Excretion of Chlorate from Yearling Ewes.
Fecal concentrations of chlorate in yearling lambs 24, 48 and 72 h after dosing with 150, 300, or 450 mg/kg BW of sodium chlorate (n = 11 per dose) are shown in Table 2 . With the exception of feces collected from control ewes, chlorate residues were present in feces collected at 24 and 48 h post-dosing regardless of dosage. Feces collected at 72 h contained no detectable residues for ewes dosed at 150 mg/kg BW; whereas, chlorate residues averaged <1.5 μg/g in sheep dosed with either 300 or 450 mg/kg BW of sodium chlorate. Regardless of dose or time of collection, fecal chlorate residues among ewes varied greatly, likely refl ecting variation in rates of digesta passage, chlorate absorption, and bacterial chlorate reduction. The magnitude of fecal chlorate residue at 24 h always averaged less than 100 μg/g of sodium chlorate and had dropped to less than 20 μg/g by 48 h, regardless of dose. Serum chlorate concentrations collected at the 24 h sampling period (Table 2) were dose related (P < 0.0003; r 2 = 0.35) but by 48 h after dosing were not (P > 0.20); meaningful regression of 48-h serum data were precluded by too few data points. At 24 h after dosing, mean serum chlorate values were 1.7, 1.3 and 1.4-fold the mean concentration of sodium chlorate in feces at the 150, 300 and 450 mg/kg BW doses, respectively. Thus, 24 h after dosing (approximately 4 halflives; described later), blood concentrations of chlorate were greater than fecal concentrations of chlorate even though the GI lumen has been typically assumed to be the "target tissue" for chlorate action.
Exp. 3: Elimination of Chlorate from Lactating Ewes
Concentrations and percentage recoveries of sodium chlorate residues in serum, milk, urine and feces of lactating ewes are shown in Table 3 . On a relative basis, the magnitude of residues in urine was greater than in serum, milk or feces at each time period. Expressed as a percentage of the dose, urine contained the largest quantities of chlorate during the 0 to 8 and 8 to 16 h collection periods at 35.4 and 19.3%, respectively. Such data are consistent with previous data showing that chlorate is rapidly absorbed from GI tracts and rapidly excreted into urine in ruminant (Smith et al., 2005a,b; Oliver et al., 2007a) and nonruminant animals (Smith et al., 2006 , Hakk et al., 2007 . Fecal concentrations of chlorate were variable within collection period, but average fecal concentrations were fairly consistent through the initial 3 collection periods (344 to 458 μg/g). Relative fecal concentrations dropped during the subsequent collection periods so that fecal matter contained a mean of 90 μg/g chlorate during the 40 to 48 h post-dose period. By 48 h, only 4.7% of the total chlorate dose had been eliminated in the feces, most of which was excreted during the initial 24 h of the study. Data in Table 3 clearly demonstrate that chlorate residues are secreted into milk and measurable chlorate residues were present to at least 48 h. A comparison of the chlorate depuration rates of milk and serum, al- Table 2 . Concentrations (mean ± SD) of sodium chlorate in blood serum and feces of yearling ewes 0, 24, 48, and 72 h after oral dosing with 0, 150, 300 or 450 mg/kg BW of sodium chlorate (Exp. 2). Serum samples were assayed by ion chromatography or LCMS assays having limits of quantifi cation (LOQ) of 0.1 (1.0 g sample) and 0.1 μg/mL (0.1 mL sample), respectively. Fecal samples were assayed by ion chromatography or LCMS having respective LOQ of 5 and 0.1 μg/g 3 Mean of 9 animals, 2 animals had NDR. 4 Mean of 10 animals, 1 sample was missing.
5 Mean of 8 animals, 3 animals had NDR. 6 Mean of 6 animals, 5 animals had NDR.
7 Mean of 4 animals, 6 animals had NDR, 1 sample was missing.
8 Mean of 4 animals, 7 animals had NDR.
though tempting, is not appropriate because serum data represent concentrations at specifi c time points; whereas, milk data represent 8 h collection periods. Regardless, chlorate concentrations in milk during the initial 8 h of the study averaged 287 μg/mL (range 196 to 401 μg/mL), which indicated that exposure of lactating ewes to oral chlorate would also expose nursing lambs to chlorate. Although delivery of chlorate to lambs via the ewe may be attractive from a production point of view, it remains to be determined if the fairly modest concentrations of chlorate in milk would be suffi cient for biological activity in lambs. An average of 1.3% of the total chlorate dose was secreted into milk during the 48-h study period, indicating that delivery of chlorate to neonates via the dam, though convenient, would be highly ineffi cient. To our knowledge, Jaartsveld et al. (1973) were the fi rst, and only, up to the time of the present study, to demonstrate that subsequent to oral ingestion of chlorate salts, chlorate residues are secreted into milk. They treated lactating dairy cattle with potassium chlorate to treat "acetonurie" (presumably ketosis); chlorate was detectable in milk from 1 cow for up to 96 h after the last of 3 daily 40-g doses (Jaartsveld et al., 1973) . In the same herd, however, milk from 2 cows contained no detectable chlorate residue 24 h after similar treatment. Body weights of cows were not provided, but assuming BW of 400 to 600 kg, the corresponding doses on BW basis would have been 67 to 100 mg/kg. Sodium chlorate is not approved for use in dairy goats or cattle, but these data clearly indicate that should approvals be granted for commercial uses in livestock, off-label use of chlorate in dairy animals would lead to residues in milk. Urine was the main excretion route for chlorate in lactating ewes with concentrations averaging over 1,000 μg/mL during the initial 40 h of the lactating ewe study. Urine in the 40 to 48 h collection period still contained nearly 0.5 mg/mL sodium chlorate. By 48 h, an average of 73% of the sodium chlorate dose was excreted as urinary chlorate residue and over 50% of the chlorate excreted in urine was eliminated during the fi rst 8 h of the study. Total recovery of chlorate ( that present in milk, urine and feces) represented an average of 73% of the dose; again approximately 50% of the recovered chlorate dose was eliminated in the initial 8 h of the study. Total recovery of 73% of the dose as chlorate in excretory fractions is consistent with balance studies using radiolabeled chlorate where large quantities of chlorate are rapidly excreted into urine. In studies using radiolabeled sodium chlorate, radioactivity remaining in tissues is present primarily as innocuous metabolites of chlorate. For example, studies in cattle (Smith et al. 2005 a,b) , swine (Smith et al., 2006) , broilers and rats (Hakk et al., 2007) have clearly demonstrated that residues not excreted within 24 h are present in tissues primarily as chloride ion. Typical concentrations of chlorate residues in tissues after 24 h of withdrawal were well under 1 μg/g.
Estimates of half-lives of chlorate elimination in milk and urine, calculated using non-linear regression of a onephase exponential decay curve, were 27 and 19 h, respectively (r 2 = 0.83 and 0.69, respectively). The half-life of fecal elimination was 9.9 h, based on the regression of data collected from the 16 to 24 h time period (peak fecal concentration) through 48 h. Depuration half-lives using pooled values of urine, milk and feces overestimate true half-lives relative to estimates calculated from point-in-time samples, but could be useful for conservative estimates of the times required for complete elimination from the body. Figure 1 shows the relationship of serum chlorate concentration (± SEM; n = 6) and time in lactating ewes dosed with 450 mg/kg BW of sodium chlorate. Predicted concentrations, calculated from parameters estimated using noncompartmental kinetic analysis, are shown as well. Mean (± SD) absorption and elimination half-life estimates were 0.6 ± 0.5 and 6.2 ± 0.8 h, respectively, with maximal serum Table 3 . Chlorate residue concentrations (μg/g; mean ± SD) and recoveries (%; mean ± SD) in blood serum, milk, urine, and feces of lactating ewes given a single oral dose of 450 mg/kg BW of sodium chlorate (Exp. 3). Milk, urine and fecal samples were collected during the indicated time periods, and serum samples were collected at 8, 16, 24, 32, 40 , and 48 h after dose treatment. Limits of quantitation for the serum, milk, urine and fecal assays were 0.250 μg/mL, 0.5 μg/mL, 100 μg/mL, and 25 μg/g, respectively, for the most sensitive assay used concentrations of 662 ± 171 μg/mL occurring at 2.0 ± 1.0 h. Due to chlorate's rapid excretion, the estimated volume of distribution was 43.5 ± 4.9 L or 0.56 ± 0.08 L/kg BW; clearance was estimated to be 0.06 ± 0.01 L/h/kg BW. Figure 2 shows the time-dependent serum concentrations of sodium chlorate in wethers after oral administration of 14 or 42 mg/kg BW of sodium chlorate. Maximal predicted serum concentrations were 3.7 ± 1.3 and 15.5 ± 0.9 μg/mL at 0.9 ± 0.2 and 1.6 ± 0.5 h, for the 14 and 42 mg/kg BW doses, respectively. Estimated absorption half-lives were 0.2 ± 0.1 and 0.6 ± 0.3 h, and elimination half-lives were 2.5 ± 0.5 and 2.7 ± 0.1 h, respectively for the 14 and 42 mg/kg BW doses. Estimated cl earance was 0.91 ± 0.26 and 0.47 ± 0.06 L • h −1 • kg −1 BW for 14 and 42 mg/kg BW doses, respectively.
Exp. 4: Kinetics and Fate of Low-Dose Sodium Chlorate and Methemoglobin Formation in Wethers
Neither absorption half-life (P = 0.63) nor time of maximal chlorate concentration were linearly related to dose (P > 0.40) when the kinetic parameters from the ewe lactation (Exp. 3) and wether (Exp. 4) studies were graphed as a function of dose (Figure 3) . Elimination halflife, however, increased linearly with dose (P < 0.004). Although clearance (L • h −1 • kg −1 BW) was not linearly related to dose (P > 0.31), the relationship between clearance and dose was nicely described (r 2 = 0.91) using a fi rst-order decay equation. Concentrations and recoveries of chlorate eliminated into urine of wethers are shown in Table 4 . Consistent with data from other studies in ruminants (Smith et al., 2005a,b) and with other experiments in this study, chlorate was excreted rapidly in urine with the greatest amounts eliminated within 12 h of dosing. Total recovery of dosed chlorate in the urine averaged 7.8% for the lesser dose (14 mg/kg BW) and 12.4% for the greater dose (42 mg/kg BW). Both values are much less than the 67% of the 450 mg/kg BW dose excreted in the urine of lactating ewes from Exp. 3. In cattle dosed for 3 consecutive days with 62.5 or 131 mg/kg BW of radiolabeled sodium chlorate, 39 and 47% of the total administered radioactivity, respectively, was eliminated in urine during a 56 h collection period (Smith et al., 2005b) , with most of the urinary radioactivity being parent chlorate. In an additional study using radiolabeled sodium chlorate (Smith et al., 2005a) , cattle were administered 21, 42 or 63 mg/kg BW of sodium chlorate as a single bolus dose. Urine from these animals contained 6.8, 13.3 and 25.3% of the dose, respectively, as parent chlorate during the 48-h collection period. Thus, urinary chlorate concentrations of wethers from this experiment are consistent with other studies in ruminants where recovery of chlorate in the urine is dose-related.
Methemoglobin concentrations in untreated wethers were 0.4 ± 0.1% (n = 6; mean ± SD) and 0.3 ± 0.1% (n = 84) across all times in treated wethers. There were no indications that methemoglobin had formed subsequent to sodium chlorate treatment in wethers at any time point. These results are consistent with those of Anderson et al. (200l) who measured 0.3% methemoglobin in blood collected from swine 8 h after a 80 mg/kg BW dose of sodium chlorate. The formation of methemoglobin is an indicator of acute chlorate poisoning in nonruminant (Steffen and Wetzel, 1993) and ruminant species (Moore, 1941; Blakley et al., 2007) , including sheep (Holzer and Stöhr, 1950) . In livestock, most toxic exposures to chlorate have been associated with its use as a broad spectrum herbicide (Moore, 1941; Holzer and Stöhr, 1950) , after animals gained access to storage areas of chlorate salts (Blakley, 2007) or after the mistaken use of chlorate as a major feed ingredient (Gregory et al., 1993) . Sheep dosed with as much as 450 mg/kg BW in this study (Exp. 3) did not show obvious signs of chlorate toxicity, but methemoglobin formation, which might indicate the initiation of toxic events, was only assessed after smaller chlorate doses (<42 mg/kg BW).
Concluding Remarks
Collectively, the results from these experiments suggest that when sheep are provided a bolus dose of sodium chlorate, the bulk of the dose is removed from the GI tract in a rapid manner that, within the constraints of the relatively small data set, does not appear to be rate limiting. Thus, one would expect that with an absorption half-life of approximately 0.6 h, roughly 94% of an oral dose would be removed from the GI tract within 2 to 3 h. Times of digesta passage through the GI tract after ingestion are considerably greater than 0.6 h, so one would not expect copious quantities of chlorate to move down the tract with digesta. Data from Exp. 1, 2, and 3 seem to validate this notion with GI tract contents and fecal matter containing small to marginal amounts of chlorate. While feces collected from lactating sheep 8 to 24 h after dosing with 450 mg/kg BW contained almost 400 μg/g of sodium chlorate, this quantity represented only 1.5% of the total amount of sodium chlorate dosed. Concentrations of chlorate eliminated in fecal matter, or contained in GI contents, of sheep dosed with lesser amounts of chlorate were decreased. Thus, it is important to note that most of the chlorate that was orally dosed in sheep never reached its "target" tissue, which was the lower GI tract.
Numerous studies indicate, however, that oral sodium chlorate is effective at reducing the numbers of Salmonella, shiga-toxin producing E. coli, or generic E. coli in GI tracts or feces of ruminants and non-ruminants. The absence of appreciable concentrations of lower GI sodium chlorate suggests that chlorate cannot mediate effects on target bacterial populations within the lumen of the lower GI tract. One possible explanation is that greater initial concentrations of chlorate may have an immediate local effect on bacterial numbers in upper portions of the GI tracts of dosed animals, these local effects could be carried down the tract with digesta fl ow. Such an explanation does not satisfactorily account for the activity of chlorate in non-ruminant animals; however, where a purging effect on E. coli or Salmonella would not be expected in the upper GI tract. In addition, in vitro studies typically require chlorate concentrations of 5 to 15 mM (530 to 1600 mg/L) to be effective; chlorate concentrations in feces from any experiment of this study did not achieve concentrations this great.
Although counterintuitive, chlorate could mediate its antibacterial effects systemically. Salmonella and E. coli O157:H7 are associated with the lower tract mucosal crypts and lymphoid tissues (Naylor et al., 2003; Moxley et al., 2004; Santos et al., 2009) ; because chlorate concentrations in serum exceeded the concentrations in all matrices other than urine at a given time period, chlorate could be delivered to sites of colonization by movement from systemic circulation through the lamina propria. Such a hypothesis could be tested fairly easily by investigating the effects of intravenous chlorate infusion on fecal levels of generic E. coli. Studies are currently underway to test the validity of this hypothesis. 
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